News
Crossed
Your contact person

Jan Phillip Denkers
Manager PR & Communications
T +49.40.593 62 61-23
E-Mail

Filter reset
In September 2022, Hans-Åke Fabricius presented the company CELL RECEPTOR and the developed method at the LSN event "Ins Netz gegangen".

Biotech & Pharma, LSN

Welcome to LSN e.V.: CELL RECEPTOR

Today, cancer treatment primarily involves the use of toxic agents, highly cell-damaging physical agents such as radiation, or other severe procedures. Undesirable and sometimes serious side effects …

Research, Academia & Universities

Molecular water research for life

Water is key to life on our planet and plays a central role in human cells, clouds in the atmosphere, water-based catalysts in industry, and many other important systems.
Winner of the Eppendorf

Research, Academia & Universities

Eppendorf & Science Prize 2022

The American scientist Ann Kennedy, Ph.D., Assistant Professor at Northwestern University, Chicago, USA has won the 2022 Eppendorf & Science Prize for Neurobiology for her work on the neural …
Group photo from left to right: Manuel Izquierdo (SXP, EuXFEL), Massimo Altarelli (former managing director EuXFEL), Reinhard Brinkmann and Wim Leemans (both DESY), Nicole Elleuche and Robert Feidenhans

Research, Academia & Universities

European XFEL celebrates 5 years of user operation

European XFEL has celebrated its fifth anniversary of user operation and began the commissioning of a new instrument in the presence of State Secretary Judith Pirscher from the Federal Ministry of …
For academic research, MHH will receive access to the data generated within the partnership by working with Evotec’s AI-driven analytics software PanHunter. (Picture: © Evotec)

Biotech & Pharma, Research, Academia & Universities

Evotec enters partnership with Hannover Medical School

Evotec SE announced that the Company has entered a partnership with Hannover Medical School (“MHH”), one of the leading German universities, to generate a molecular patient database for Sjögren’s …

Forschung & Hochschulen 

Fighting Chronic Diseases and Cancer

For the study, which has now been published in the journal Antioxidants, the team led by experimental physicist Florian Grüner of the University of Hamburg examined Q10 molecules which they had …
New construction receives platinum sustainability certificate from the German Sustainable Building Council. (Source: © Eppendorf SE)

Biotech & Pharma

Eppendorf expands high-tech site in Jülich

The globally positioned Eppendorf Group is expanding its bioprocess site in Jülich, Germany with the construction of a new state-of-the-art multifunctional building. The topping-out ceremony in …
Preview of the new biologics manufacturing plant J.POD® Toulouse, France (EU); (Image: © Brunerie

Biotech & Pharma

Evotec initiates ground-breaking for new biologics facility

Evotec SE today officially launched the construction of its J.POD® biologics manufacturing facility at Evotec’s Campus Curie in Toulouse, France. J.POD® Toulouse, France (EU), the second facility of …
FUSE-AI starts global sales at the G20 Digital Innovation Network in Indonesia. (Image: © FUSE_AI)

Digitalisation

FUSE-AI takes off

The G20 Digital Innovation Network is a high-level forum for sharing knowledge, fostering discussion and building partnerships between global innovation players. It aims to serve as a bridge for …
Dr. Christian Regenbrecht, CEO of CELLphenomics (2nd from left) and Prof. Dr. Hartmut Juhl, CEO and founder of Indivumed (2nd from right) are pleased about the agreed partnership. ( Picture: © Indivumed)

Biotech & Pharma

Indivumed and CELLphenomics Announce Partnership

Indivumed GmbH (“Indivumed”) and CELLphenomics GmbH (“CELLphenomics”) today announced a partnership to create a unique platform for faster and more efficient discovery and validation of therapeutic …
Repurposing drugs as the new normal (Photo: © Fraunhofer ITMP

Biotech & Pharma, Research, Academia & Universities

REMEDi4ALL project launched

REMEDi4ALL is expected to make a major leap forward in drug repurposing, or finding new therapeutic option for existing drugs, in areas where there are high unmet medical needs. It will receive 23M …
The paper

Biotech & Pharma, Research, Academia & Universities

Natural substances show promise against coronavirus

Three natural compounds present in foods like green tea, olive oil and red wine are promising candidates for the development of drugs against the coronavirus. In a comprehensive screening of a large …